- Home
- / SciClone Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
SciClone Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$160.1 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 133.6M | 156.3M | 127.1M | 134.8M | 157.3M | 160.1M |
| Revenue growth, % | 6.1% | 16.7% | 1.8% | |||
| General and administrative expense | 24.0M | 21.4M | 32.5M | 22.7M | 27.9M | 34.2M |
| Operating expense total | 72.9M | 134.5M | 89.5M | 71.2M | 81.9M | 88.9M |
| EBIT | 29.4M | 6.4M | 10.4M | 26.0M | 29.9M | 33.2M |
| EBIT margin, % | 22.0% | 4.1% | 8.2% | 19.3% | 19.0% | 20.8% |
| Pre tax profit | 29.3M | 6.3M | 13.2M | 26.4M | 30.3M | 34.1M |
| Income tax expense | 798.0K | (3.3M) | 2.2M | 1.2M | 807.0K | 3.4M |
| Net Income | 28.5M | 9.6M | 11.0M | 25.2M | 29.5M | 30.7M |